English 
Chinese
Reducing Total Cost of Ownership
It's a tough question that every pharmaceutical company faces - how do you ensure quality and reliability of a drug product while reducing costs? The answer: Reduce your total cost of ownership.
Issues like breakage and delamination can result in costly recalls. By selecting the proper containment and delivery systems for your drug products early in the development process, you may be able to avoid these issues.
Through early partnerships, West can help manage the cost of ownership through:
- Lifecycle management
- Integrated containment and delivery
- Regulatory and technical expertise
Read the following Case Studies to see how West can help:
NOVAPURE® COMPONENTS
Daikyo Crystal Zenith® sOLUTIONS
Daikyo Crystal Zenith® Components
Daikyo Crystal Zenith® Solutions
Envision™ Verification
Envision™ Verification
NovaPure® Components
Partnering to Ensure High Quality & Optimized Functional Performance Based on Quality by Design (QbD)
Click Here
Daikyo Crystal Zenith® is a registered trademark of Daikyo Seiko, Ltd.
NovaPure®, AccelTRA™ are registered trademarks or trademarks of West Pharmaceutical Services, Inc. in the United States and other jurisdictions.
